格林威治标准时间2131 - 医疗器械制造商Fisher & Paykel Healthcare的股价上涨4.8%，抹去本月的所有损失，投资者对其年度利润指引的上调表示欢欣。F&P Healthcare现在预计2026财年净利润将达到4.1亿新西兰元至4.6亿新西兰元，高于之前的预期3.9亿新西兰元至4.4亿新西兰元。该公司还指出，年度收入将更高，预计在21.7亿新西兰元至22.7亿新西兰元之间。杰弗里分析师范妮莎·汤普森表示，持续的临床变化、新产品及业务效率提升推动了这一上调。杰弗里将F&P Healthcare评为买入，给予目标股价为44.40新西兰元/股。F&P Healthcare在周三交易的前半小时内股价上涨至38.45新西兰元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.